前收市價 | 75.16 |
開市 | 77.18 |
買盤 | 77.00 x 0 |
賣出價 | 77.16 x 0 |
今日波幅 | 77.16 - 78.18 |
52 週波幅 | 68.02 - 90.62 |
成交量 | |
平均成交量 | 0 |
市值 | 無 |
Beta 值 (5 年,每月) | 無 |
市盈率 (最近 12 個月) | 無 |
每股盈利 (最近 12 個月) | 無 |
業績公佈日 | 2024年7月29日 - 2024年8月02日 |
遠期股息及收益率 | 無 (無) |
除息日 | 無 |
1 年預測目標價 | 無 |
BioMarin (BMRN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Plain-as-day bargains can still be found, even with the innovation-fueled Nasdaq Composite powering to a fresh all-time high.
We live in the best of times where life is not capped at 45 or 50 years of age, all thanks to wonderful discoveries in the field of biotechnology. The resources being invested to produce new drugs and treatment methodologies are increasing day by day. Every discovery opens a new chapter of success for the companies operating in the biotech sector. As the trend continues, biotech companies are recording remarkable stock performances and revenue milestones. Many analysts have started to analyze th